Structure Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GPCR and other ETFs, options, and stocks.

About GPCR

Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its pipeline includes Aleniglipron GSBR-1290, ACCG-2671, GIPR, GCGR, ANPA-0073, and LTSE-2578. 

CEO
Raymond C. Stevens
CEORaymond C. Stevens
Employees
163
Employees163
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
2019
Founded2019
Employees
163
Employees163

GPCR Key Statistics

Market cap
1.33B
Market cap1.33B
Price-Earnings ratio
-10.06
Price-Earnings ratio-10.06
Dividend yield
—
Dividend yield—
Average volume
1.61M
Average volume1.61M
High today
$24.45
High today$24.45
Low today
$23.05
Low today$23.05
Open price
$23.57
Open price$23.57
Volume
768.19K
Volume768.19K
52 Week high
$62.74
52 Week high$62.74
52 Week low
$13.22
52 Week low$13.22

Analyst ratings

100%

of 13 ratings
Buy
100%
Hold
0%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.